Figure 2. Prognostic significance of DE-ATGs in GC. (A–C) Kaplan-Meier curves for three prognostic DE-ATGs (CXCR4, DLC1, and MAP1LC3C) related to immunity in patients with GC (P < 0.05). (D–F) The expression level of CXCR4, DLC1, and MAP1LC3C in high- and low-macrophage infiltration groups. (G–I) GEPIA-based validation that DE-ATGs (CXCR4, DLC1, and MAP1LC3C) are effective prognostic indicators and risk factors for GC. (J–L) Tree diagram of a multivariate regression analysis for CXCR4, DLC1, and MAP1LC3C with other clinical variables.